Nash Marc 4
4 · Outset Medical, Inc. · Filed May 16, 2025
Insider Transaction Report
Form 4
Nash Marc
EVP Operations R&D & Service
Transactions
- Sale
Common Stock
2025-05-15$17.82/sh−252$4,491→ 13,465 total
Footnotes (2)
- [F1]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c).